Interview with Chor Eng Cheah, Head of Invidia Malaysia and Singapore, Invida…
When we spoke to Herbert Dittmar of Bayer, he said that there were no specific challenges in Malaysia that could not be found elsewhere. How do you convince companies of…
Address: Level 2, No 10 Jalan Bersatu 13/4, 46200 Petaling Jaya, Selangor, Malaysia
Tel: -15028
Invida improves the lives of patients in Asia by commercializing differentiated pharmaceutical products of superior quality. We do this through our proven brand and sales know-how, strong expertise across a number of key therapeutic categories, and deep experience in all critical Asia Pacific countries. Comprehensive functional capabilities provide rapid market access delivered by our passionate team of professionals.
Invida operates in the fastest growing healthcare markets worldwide, increasing at an annual compounded growth rate of 12 percent, more than double the global growth rate for the sector. Today, the Asia Pacific markets represent approximately US$50 billion and 10 percent of worldwide pharmaceutical sales.* With China and India among top growth contributors globally, Invida is currently implementing a long-term strategy to establish itself as a leader in these rapidly expanding markets through targeted investments.
With more than 4,000 employees throughout Asia Pacific, Invida operates throughout the commercial value chain from regulatory approval and product launch to lifecycle management. We manage a portfolio of proprietary healthcare brands as well as licensed products from biotech and multinational companies. Partnering is a critical component of Invida’s business model.
When we spoke to Herbert Dittmar of Bayer, he said that there were no specific challenges in Malaysia that could not be found elsewhere. How do you convince companies of…
Herbal Science started in 1985 as team of two pharmacists and now represents a large 200-person operation. What have been the main challenges for the company in this transformation and…
The society started at the beginning of the 20th century with the combination of the Penang Pharmaceutical Association and the Straits Pharmaceutical Association. Have there been significant shifts in the…
Would you begin by giving our readers a brief overview of the recent changes in the Ministry of Health’s focus? After Prime Minister Najib changed Malaysia’s economic policy from the…
How would you describe MABIC today and the way that it has evolved since its creation in 2000? The Malaysian Biotech Information Centre or MABIC is an NGO and part…
In the same week that you announced a rise in your Q3 profits your Managing Director resigned. How have you managed to achieve this increase in profits despite management uncertainties…
Would you start off by giving our readers some of CCM’s background? CCM started in Malaysia as part of the ICI group of companies in 1930. In the 1960s ICI…
See our Cookie Privacy Policy Here